Full-Time

Head of Digital Marketing Strategy

Digital Marketing, Strategy

Posted on 9/23/2025

Philips

Philips

Manufactures sleep therapy and respiratory devices

Compensation Overview

$176k - $282k/yr

+ Annual Incentive Bonus

No H1B Sponsorship

Cambridge, MA, USA

In Person

Candidates must reside in or within commuting distance to Cambridge, MA. This is an office role requiring full-time presence in the company’s facilities.

Category
Growth & Marketing (1)
Required Skills
Marketing
Requirements
  • 10+ years of experience in Digital Marketing, developing and leading Digital Strategy required
  • Global and regional digital strategy development, preferably within the healthcare or life sciences, diagnostics, or pharma industry
  • Agency experience and working in a matrixed environment a plus
  • Deep understanding of customer decision journeys and digital engagement strategies
  • Marketing Technology landscape, with experience defining requirements and driving teams to develop needed solutions to support the digital strategy and customer and stakeholder needs
  • Experience working in a large global company required
  • Bachelor's degree in Business, Marketing, Digital Media, or related field, required
  • MBA preferred
Responsibilities
  • Develops a comprehensive E2E Digital Strategy and Roadmap to evolve our capabilities and grow our Global digital order book by delivering on business and customer impact goals
  • Works closely with region and business teams across disciplines to build a comprehensive and underpinned holistic strategy while gaining buy-in and alignment to ensure success
  • Develops an impact focused digital marketing technology strategy and approach and leverage a team of digital platform SMEs to implement and drive this globally
  • Engage and negotiate with IT and Operational leadership to align and secure support
  • Manages deployment manager resources to ensure our highest priority, most complex and cross-functional programs are executed on time, per plan, and achieve intended outcomes
  • Infuses the best of outside-in thinking combined with internal best practices to form a winning future direction for our digital ecosystem
  • Leverages digital trends from the healthcare industry, emerging technologies, competitor activities and market dynamics to drive innovation and differentiation
  • Responsible for delivering the E2E Digital Strategy to the Marketing Leadership Council (all senior marketing leaders across Philips) and for gaining buy-in, alignment, and support to the plan
  • Develops and maintain a wide network of internal stakeholders and advocate and negotiate for support across several functions (Businesses, Regions, IT, Supply Chain, Quality, Regulatory, Legal, etc.) to build strong relationships and facilitate open communication to drive consensus and enable successful execution
  • Owns development of business cases to support the Digital Strategy, Roadmap, and Plan, garnering support and alignment to digital program costs and ROI
Desired Qualifications
  • Performance-oriented mindset with a track record of owning and achieving/exceeding KPIs
  • Excellent communication and interpersonal skills, with the ability to influence and collaborate effectively across all levels of the organization, including senior executives
  • Demonstrated ability to thrive in a fast-paced, dynamic environment and drive results in a cross-functional team setting
  • Ability to manage a diverse set of stakeholders, across functions and geographies with a high attention to detail and a passion for problem-solving, learning, and educating others

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE